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Glioblastoma is a malignant human cancer that confers a dismal prognosis. Ionizing radiation (IR) is
applied as the standard treatment for malignant gliomas. However, radiotherapy remains merely palli-
ative because of the existence of glioma stem cells (GSCs), which are regarded as highly radioresistant
“seed” cells. In this study, the effect and possible mechanisms of radiotherapy in combination with
resveratrol (Res) were investigated in a radioresistant GSC line, SU-2. Our results showed that Res
inhibited SU-2 proliferation and enhanced radiosensitivity as indicated by clonogenic survival assay. We
also observed a decrease in the expression of neural stem cell marker CD133, which indicated that
treatment with Res and IR induced SU-2 cell differentiation. In addition, the combination of Res with IR
signiﬁcantly increased autophagy and apoptosis levels in both in vitro cells and nude mouse model.
Finally, Res signiﬁcantly attenuated the repair of radiation-induced DNA damage. Taken together, the
present study demonstrated that the signiﬁcant radiosensitization ability of Res both in vitro and in vivo
was attributed to its synergistic antitumor effects, including inhibition of self-renewal and stemness,
induction of autophagy, promotion of apoptosis, and prevention of DNA repair. Therefore, Res may
function as a radiation sensitizer for malignant glioma treatment.
© 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Glioblastoma (GBM) is the most frequent and highly aggressive
primary brain tumor in adults, characterized by increased prolif-
eration, resistance to radiotherapy and chemotherapy, and invasion
into surrounding normal brain tissues (1,2). The current standard
treatments for malignant gliomas include surgical resection, radi-
ation therapy, and chemotherapy (3,4). Unfortunately, the prog-
nosis of patients with GBM remains extremely poor because of the
radioresistance of malignant gliomas despite recent technical ad-
vances in radiotherapy (5). However, a growing body of evidence
suggested that only a subpopulation of malignant glioma cells,
named glioma stem cells (GSCs), are resistant to radiation therapy,
and this property contributes to the poor treatment outcomes
associated with these tumors (6e8). Consequently, this cell popu-
lation may be targeted to develop new molecular therapies against
GBM.ng).
rmacological Society.
. Production and hosting by ElseResveratrol (3,40,5-trihydroxystilbene, Res), a potential radiation
sensitizer for tumor treatment, which is a naturally occurring
phytoalexin enriched in enormous dietary products, has attracted
research attention because of its cardioprotective, antioxidant, and
anti-inﬂammatory activities and cancer chemopreventive proper-
ties (9,10). Recent studies have revealed that Res has growth
inhibitory activity, and it induces apoptotic or autophagic cell death
in a number of human cancer cell lines and in animal models of
carcinogenesis (11e14). Res inhibits cell proliferation and stimu-
lates apoptosis through activation of the mitochondrial apoptotic
pathway in human retinoblastoma cells (15). Res can also induce
ovarian cancer death through two distinct pathways: apoptosis and
autophagy (16). Yu et al. suggested that Res can inhibit the acti-
vation of STAT3 signaling of medulloblastoma cells, and it may
further induce medulloblastoma cells to growth arrest and
apoptosis (17). Several groups have demonstrated that Res en-
hances radiation sensitivity in prostate cancer by inhibiting cell
proliferation and promoting cell senescence and apoptosis (18,19).
Hence, Res plays crucial roles in anti-proliferative, pro-apoptotic,
and radiosensitizing effects on various cancer cells.
Previous studies in our laboratory have shown that Res exerts
growth inhibitory effects on glioma U251 cells in a time- and dose-vier B.V. This is an open access article under the CC BY-NC-ND license (http://
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roles in Res-induced death of U251 cells (20). Furthermore, we have
demonstrated that autophagy plays an essential role in the regu-
lation of self-renewal, differentiation, tumorigenic potential, and
radiosensitization of GSCs (21). However, the potential radio-
sensitization effect of Res and its mechanisms in GSCs both in vitro
and in vivo have not been clearly revealed. Given the important role
of GSCs in radioresistance, the potential radiosensitization effect of
Res on GSCs and its possible mechanisms should be investigated to
determine its therapeutic value in preventing or treating this
disease.
2. Materials and methods
2.1. Cell culture
Human GSC line SU-2 was obtained from a surgical specimen of
a patient with mixed tumors containing anaplastic astrocytoma
and ependymal cells (21,22). The cells were cultured at 37 C in an
atmosphere with 5% CO2 in DMEM/F12 (Gibco Life Technologies,
Paisley, UK) in the presence of recombinant human ﬁbroblast
growth factor (bFGF; 20 ng/mL; Invitrogen), recombinant human
epidermal growth factor (EGF; 20 ng/mL; Invitrogen), and N2
supplement (Gibco Life Technologies) according to protocols in the
literature (22). The cells were then differentiated in the presence of
serum or in the absence of bFGF and EGF.
2.2. Reagents
Res (Sigma, St Louis, MO, USA, Lot: R5010) was dissolved in
dimethyl sulfoxide (DMSO; Sigma Aldrich, St. Louis, MO, USA) to
produce a 100 mM stock solution, which was aliquoted, stored
at 20 C, and diluted to the desired ﬁnal concentration in DMEM/
F12 at the time of use.
2.3. Radiation treatment and clonogenic survival assay
Cells or mice were irradiated with a 6 MV X-ray linear acceler-
ator (model: PRIMUS, D. E., Siemens A&D LD) at a dose rate of
198MV/min. Clonogenic survival assay was performed as described
previously (23). The number of colonies with at least 50 cells was
counted. Surviving fraction (SF) was calculated as: mean colony
count/cells inoculated  plating efﬁciency.
2.4. Immunoﬂuorescence
Immunoﬂuorescence, monodansylcadaverine (MDC) staining,
and Hoechst 33258 staining were conducted as described previ-
ously (23). The anti-CD133 antibody (1:100; Millipore), secondary
antibody conjugated to Alexa 488 (Invitrogen), and Hoechst 33258
(0.5 mg/mL; KeyGEN) were used in the study.
2.5. Western blot analysis
Western blot was performed as described previously (23). The
following antibodies were used: rabbit anti-LC3 (1:1000; Abcam),
rabbit anti-Beclin-1 (1:1000; Abcam), mouse anti-Bcl-2 (1:500;
Abcam), and mouse anti-b-actin (1:1000; Cell Signal). Membranes
were washed again with TBST and scanned with the Odyssey
Infrared Imaging System (LI-COR).
2.6. Transmission electron microscopy (TEM)
The ultrastructure of SU-2 cells after treatment with or without
ionizing radiation (IR) in the presence or absence of Res wasdetermined by TEM as described previously (24). Tumor tissues
obtained from mice bearing GSCs were cut serially into ultrathin
sections and ﬁxed with 2.5% glutaraldehyde at 4 C for 2 h, followed
by a second ﬁxation with OsO4, ethanol dehydration, inﬁltration,
embedding, and ultrathin sectioning by diamond knives. The slides
were viewed by TEM with a Philips CM120 electron microscope at
the voltage of 100 kV.2.7. Annexin V-FITC/PI staining
The percentage of apoptosis was analyzed by ﬂow cytometry
with FITC/PI kit (KeyGEN, Nanjing, China) according to the manu-
facturer's recommendations. Cells in the earlier stages of apoptosis
were stained positive for annexin V-FITC, whereas those in the later
stages of apoptosis were stained positive for both annexin V-FITC
and PI.2.8. Neutral comet assay
As a measure of DNA repair in SU-2 cells, the neutral comet
assay was employed as previously described (23). DNA damage
under each condition was quantiﬁed as follows: number of cells
with the comet's tail/number of total cells  100%.2.9. Animal experiments
All animal experiments were conducted in accordance with the
humane treatment of animals under institutional guidelines
approved by the Ethical Committee of Soochow University. The
mice were housed in individually ventilated cages in the Animal
Laboratory of the Medical College of Soochow University. Food and
water were freely available.
Five-week-old male nude (BALB/c) mice were used in the pre-
sent study. To generate tumor xenografts, 5  106 SU-2 cells in the
logarithmic growth phase were implanted subcutaneously into the
right forelimb of BALB/c nude mice. Xenografts were allowed to
grow to approximately 100 mm3 over two weeks and randomly
divided into four groups (n ¼ 5 in each group): Con (100 mL, saline
solution), IR (X-ray, 6 Gy), Res (150 mg/kg), and IR þ Res (6 Gy,
150 mg/kg). Res were administered by intraperitoneal injection
every other day for two weeks, and the IR treatment was given
twice on day 3 and on day 9 with a dose rate of 2 Gy/min until 6 Gy
IR had been delivered. Mice received local irradiation as described
elsewhere (25). From the day of intervention, the longest diameter
(a) and shortest diameter (b) of the tumor were measured using
digital calipers every 3 days, and the tumor volume
(V ¼ 0.5  a  b2) was calculated. The individual relative tumor
volume (RTV) was calculated as follows: RTV ¼ Vt/V0, where Vt is
the volume on each day, and V0 is the volume at the beginning of
the treatment. Themental state, feeding, activity, urine, and feces of
nude mice were observed during the experiment. At the end of the
experiments, subcutaneous tumors were harvested following ani-
mal sacriﬁce by cervical dislocation. Tumor samples were excised
for Western blot, ﬁxed in 4% paraformaldehyde, and cut into 4 mm
serial sections for TEM analysis.2.10. Statistical analysis
All the experiments were repeated independently at least three
times, and data were presented as the mean ± SD (standard devi-
ation). Datawere statistically analyzed using a two-tailed Student t-
test. A p value of 0.05 was considered the boundary of statistical
signiﬁcance. All analyses were performedwith GraphPad Prism 5.0.
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3.1. Res inhibits GSC proliferation and enhances radiosensitivity
Clonogenic assay was performed to determine whether the
combination of Res and IR leads to radiosensitization of GSCs. We
examined the effects of IR, Res, and IR þ Res on cell survival. As a
result, cells treatedwith Res or IR alone produced a reduced number
of colonies compared with the group that was untreated, but the
combination of Res and IR could generate a signiﬁcantly reduced
number of colonies compared with the group without treatment
(Fig. 1A). Student's t-test was performed on the SF values to
demonstrate clonogenic assay studies. The analysis was performed
bycomparing SFof untreated (SF¼1)with SFof Res (SF¼0.85±0.1),
IR (SF ¼ 0.81 ± 0.1), or IR þ Res (SF ¼ 0.2 ± 0.1) at 6 Gy. Cells pre-
viously treated with Res and IR generated a decreased number of
colonies compared with untreated cells (p < 0.05, SF ¼ 0.2 ± 0.1 for
IRþ Res) (Fig.1B). These ﬁndings suggested that the combination of
Res and IR signiﬁcantly reduced the colony formation capacity of
GSCs and signiﬁcantly increased radiation sensitivity in GSCs.
3.2. Res attenuates self-renewal and reduces the stemness of GSCs
Self-renewal is a key feature of stem cells. The self-renewal
ability of cancer stem cells (CSCs) is essential for tumorigenesisFig. 1. Resveratrol inhibits GSC proliferation and enhances radiosensitivity. (A) Clonogen
IR þ Res (0e6 Gy and 75 mmol/L). (B) Clonogenic survival curves for IR (2, 4, and 6 Gy) alone o
**p < 0.01 compared with the IR alone group.and tumor development (26). Therefore, we evaluated the effect of
combined Res and IR on the self-renewal of GSCs based on the
ability of GSCs to generate neurospheres. After cells were cultured
in serum-free media with bFGF and EGF for a week, the number of
neurospheres was counted to calculate the neurosphere formation
rate: neurosphere formation rate¼ (number of neurospheres/
number of inoculated cells)  100%. Relative to cells in the control
and IR-treated group, cells in the co-treatment group became more
attached to the culture plate, losing their spherical shape and
forming cell processes as indicated by arrows (Fig. 2A), and the
neurosphere formation rate and size of the newly formed neuro-
spheres in IR þ Res group were remarkably decreased (Fig. 2B). The
results suggested that the combination of Res and IR reduced the
self-renewal ability of GSCs. To determine the effects of Res on the
stemness of GSCs, we used immunocytochemical assay to detect
changes in expression levels of neural stem cell marker CD133 after
treatment for 48 h in various treatment groups. Compared with the
control and IR groups, the expression of CD133 was reduced in the
Res group. However, the level of CD133 in the co-treatment group
almost disappeared, together with the loss of spherical shape
(Fig. 2C). This result demonstrated that Res and IR reduced the
expression of the neural stem cell marker CD133 of GSCs in vitro.
Overall, our results indicated that combined Res and IR not only
deregulated the self-renewal of GSCs but also reduced the stemness
of GSCs. These results indicated that the combination of Res and IRic survival assay in SU-2 cells treated with IR alone (0e6 Gy), Res alone (75 mmol/L) or
r both Res (75 mmol/L) and IR (2, 4, and 6 Gy) treatment within GSCs. Mean ± SD. n ¼ 3.
Fig. 2. Effect of resveratrol on self-renewal and stemness of GSCs. (A) Representative images of SU-2 neurospheres after treatment with IR, Res, or both modalities (Scale
bar ¼ 50 mm). (B) The quantiﬁcation of neurospheres formation rate and size of neurosphere formed under each condition. (C) Immunocytochemistry for the neural stem cell
marker CD133 was performed in SU-2 neurospheres after the indicated treatments on coverslips (Scale bar ¼ 20 mm). Nuclei were counterstained with DAPI. Mean ± SD. n ¼ 3.
***p < 0.001 compared with the control group. ###p < 0.001 compared with the IR-alone group.
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self-renewal and reducing stemness of GSCs.
3.3. Res-mediated radiosensitization involves increased autophagy
induction
Increasing evidence indicated that the radiosensitivity of cancer
cells is associated with the induction of autophagy (21,27, 28).
Therefore, we investigated whether Res-mediated radio-
sensitization of GSCs results from autophagy induction byperforming MDC staining, Western blot, and TEM analysis. The
autoﬂuorescent agent MDC has been introduced as a speciﬁc
autophagolysosomemarker to analyze the autophagic process (29).
We stained SU-2 cells withMDC and observed the staining patterns
using a ﬂuorescence microscope to monitor the autophagy/lyso-
somal events. After exposure of GSCs to IR, Res, or IRþ Res, the SU-2
cells that were treated with Res alone or with Res and IR showed an
increased number of MDC-positive vesicles in the cytoplasm,
particularly in the perinuclear regions (Fig. 3A). This increase sug-
gested the formation of autophagic lysosomes and an increase in
L. Wang et al. / Journal of Pharmacological Sciences 129 (2015) 216e225220the induction of autophagy. Induction of autophagy is usually
accompanied with an increase in microtubule-associated protein
light chain 3 (LC3) and Beclin-1. Another approach is to detect LC3
conversion (LC3-I to LC3-II) or Beclin-1 by immunoblot analysis,
because the amount of LC3-II is clearly correlated with the number
of autophagosomes (30). We then performed Western blot to
analyze the changes in the protein expression levels of LC3-I, LC3-II,
and Beclin-1 in GSCs with the same treatments as described above
(Fig. 3B). The quantiﬁcation of the percentage of LC3-I and LC3-II
expression in each of the treatment groups showed a remarkable
increase in the conversion of LC3-I to LC3-II in SU-2 cells that
received combined treatment (p < 0.001) (Fig. 3C). Similar results in
Beclin-1 were observed (p < 0.01) (Fig. 3C). Interestingly, the level
of LC3-II/LC3-I and Beclin-1 in the co-treated group was much
higher than that in the IR alone group (p < 0.01). TEM analysis
showed a signiﬁcant increase in double-membrane autophago-
somes in the Res-treated group and in the combination group as
indicated by arrows (Fig. 3D). Collectively, these data suggested that
the mechanism of Res-mediated radiosensitization involved the
induction of autophagy.3.4. Induction of apoptosis of GSCs by co-treatment with Res and IR
Autophagy and apoptosis usually function as partners to induce
cell death in various cancer cells (31e33). Hence, we investigatedFig. 3. Resveratrol-mediated radiosensitization involves autophagy induction. (A) SU-2 c
with IR (6 Gy), and the formation of autophagolysosomes was analyzed using MDC by immu
and analyzed for LC3, Beclin-1, and b-actin expression by Western blot analysis. b-actin was
SU-2 cells treated by indicated treatments after normalization with b-actin levels. (D) Repre
following Res treatment with IR in SU-2 cells. N, nucleus. (Scale bar ¼ 5 mm for left column
compared with the control group. ##p < 0.01 compared with the IR alone group.whether combination therapy can induce apoptosis in GSCs. We
performed annexin V-FITC/PI staining tomeasure the percentage of
apoptosis in each treatment group as mentioned above. Compared
with the untreated group, the IR alone group and Res alone group
showed a slight increase in apoptosis level; however, apoptosis in
the co-treated cells was approximately thirtyfold greater than that
in the matched untreated cells and eightfold greater than that in
the IR alone group (p < 0.001 and p < 0.01, respectively) (Fig. 4A and
B). Another corroborative assay, Hoechst 33258, which is used to
stain DNA for evaluating the cell cycle and apoptosis, was per-
formed to determine the incidence of apoptosis morphologically.
Representative microphotographs showed that morphological
characteristics of apoptosis, such as chromatin condensation and
nuclear fragmentation, were obvious in SU-2 cells treated with
both Res and IR after evaluating stained nuclei by Hoechst 33258
for 48 h (Fig. 4C). All of these data collectively indicated that radi-
ation sensitization in co-treated GSCs was due to higher rates of
apoptosis.3.5. Res impairs the repair of radiation-induced DNA damage in
GSCs
CSCs may contribute to glioma radioresistance through prefer-
ential activation of the DNA damage checkpoint response and an
increase in DNA repair capacity (34). In the present study, DNAells were treated with Res (75 mmol/L) for 12 h and then harvested 24 h after treatment
noﬂuorescence analysis (Scale bar ¼ 10 mm). (B) The cells were treated with Res and IR
used as a loading control. (C) Quantiﬁcation of LC3 and Beclin-1 protein expression in
sentative electron micrograph image showing increased formation of autophagosomes
and 0.5 mm for right column). Mean ± SD. n ¼ 3. *p < 0.05, **p < 0.01 and ***p < 0.001
Fig. 4. Induction of GSC apoptosis by co-treatment with Res and IR. (A) After treatment with IR and Res, the cells were stained with annexin V-FITC/PI. (B) The quantiﬁcation of
the percentage of apoptotic cells resulting from (A). (C) Hoechst 33258 staining. Abnormal nuclei as indicated by arrows (crenation, condensation, and fractionation) were
determined by ﬂuorescence microscopy (Scale bar ¼ 10 mm). Experiments were performed at least three times. Representative microphotographs are shown. Mean ± SD. n ¼ 3.
***p < 0.001 compared with the control group. ##p < 0.01 compared with the IR alone group.
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with a microscope at various times after IR. Compared with cells in
the untreated group, remarkable DNA damage was observed in the
other groups, but no obvious difference in DNA damage was found
between the IR alone and co-treated groups immediately after
irradiation (p < 0.001 and p > 0.05, respectively). However, DNA
damage in the co-treated groupwas more severe than that in the IR
alone group at 3 and 12 h after irradiation as reﬂected by the per-
centage of cells with the comet's tail (p < 0.001 and p < 0.05,
respectively) (Fig. 5A and B). These results suggested that co-
treated GSCs repaired DNA damage less efﬁciently than GSCs in
other groups. Therefore, Res prevented the repair of radiation-
induced DNA damage in GSCs.
3.6. Res increases autophagy and apoptosis in nude mouse model
To investigatewhether the results in vitro cells can also be found
in in vivo animal models, we performed xenograft experiments
using a xenograft modal of SU-2 cells into nude mice. After cell
inoculation for 14 days, the mice were injected with saline, Res, or
treated with IR as mentioned above. In 16 days of treatment, thetumors in the four groups increased in a time-dependent manner.
IR or Res displayed no apparent toxicity, as determined by body
weight. However, the RTVs in the co-treated and Res-treated
groups were signiﬁcantly smaller than those in the IR alone or
control group (p < 0.01 and p < 0.05, respectively). The RTVs of the
co-treated, Res alone, IR alone, and control groups were 5.58 ± 0.8,
7.04 ± 0.7, 8.92 ± 0.9, and 8.41 ± 0.6, respectively (Fig. 6A). These
ﬁndings demonstrated that combined treatment with Res and IR
resulted in a substantial growth delay and subsequent inhibition of
the growth rate of SU-2 cell xenografts.
To assess the apoptosis effect of Res combined with radio-
therapy, the level of apoptosis in GSC xenograft tumors treated as
described above was measured. The levels of Bcl-2 in the Res and
co-treated groups signiﬁcantly decreased compared with those in
the control group, and the administration of Res and IR signiﬁcantly
reduced the expression of Bcl-2 compared with the IR alone group
(p < 0.001) (Fig. 6B and C). Thus, the administration of Res and IR
increased apoptosis in vivo.
The quantiﬁcation of the percentage of LC3-I and LC3-II
expression in each of the treatment groups showed a remarkable
increase in the conversion of LC3-I to LC3-II in SU-2 cell xenografts
Fig. 5. Resveratrol impairs the repair of radiation-induced DNA damage in GSCs. (A) GSCs were treated with IR (6 Gy) and Res (75 mm/L) and then harvested at 1, 3, and 12 h after
IR. The alkaline comet assay was performed to determine treatment-induced DNA damage. Representative images of SU-2 cells at the indicated time points after various treatments
are shown (Scale bar ¼ 10 mm). (B) The quantiﬁcation of the percentage of cells with comet tails at different time points. Each group was analyzed in triplicate. Mean ± SD. n ¼ 3.
*p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control group. ##p < 0.01 and ###p < 0.001 compared with the IR alone group.
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was used to further conﬁrm the induction of autophagy. We
determined that co-treatment increased the number of double-
membrane autophagosomes, as indicated by arrows in tumor sec-
tions obtained from our in vivo tumor study (Fig. 6D).
Collectively, these data suggested that the combination of Res
and IR increased apoptosis and autophagy in our nude mouse
model.
4. Discussion
Studies on GSCs have been conducted for many years, and GSCs
have been found to contribute to the recurrence and resistance to
irradiation, a major therapeutic modality for the treatment of ma-
lignant gliomas (34e37). Radioresistance is a major obstacle tosuccessful treatment in glioma radiotherapy. The use of radio-
sensitizer holds the promise of overcoming radioresistance and
improving treatment outcomes. Therefore, novel and more effec-
tive radiosensitizers are of critical need to meet this challenge. The
overall purpose of the present study was to evaluate the effect of
Res on radiosensitivity in GSCs and further understand the mo-
lecular mechanisms of the synergistic effect of Res and radio-
therapy in the control of gliomas.We revealed for the ﬁrst time that
the signiﬁcant radiosensitization ability of Res in both in vitro GSCs
and in vivo nude mouse model was attributed to its synergistic
antitumor effects, including inhibition of proliferation, induction of
autophagy, promotion of apoptosis, and prevention of DNA repair.
In our study, as evidenced by the clonogenic assay, Res could
effectively inhibit GSC proliferation. The combination of Res and IR
signiﬁcantly reduced the colony formation capacity of GSCs (Fig. 1),
Fig. 6. Effect of resveratrol on autophagy and apoptosis in vivo. SU-2 cells (5  106 cells/0.1 mL of medium/mouse) were injected subcutaneously to generate the mouse model.
(A) The relative tumor volume of GSC tumors subcutaneously xenografted into nude mice with indicated treatments. (B) The expression of LC3 and Bcl-2 in xenograft was detected
by Western blot. (C) The quantiﬁcation of LC3 and Bcl-2 protein expression after normalization to the level of b-actin. (D) Representative electron micrograph image of auto-
phagosomes in subcutaneous xenograft of SU-2 cells treated by indicated treatments. N, nucleus. (Scale bar ¼ 5 mm for left column and 0.5 mm for right column). Mean ± SD.
*p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control group. ##p < 0.01 and ###p < 0.001 compared with the IR alone group.
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results strongly suggested a radiosensitizing role of Res in GSCs.
Emerging evidence suggested that CSCs are able to self-renew and
are refractory to cancer treatment (26,39). Indeed, the amount and
size of the newly formed neurospheres and the level of neural stem
cell marker CD133 decreased in the co-treatment group (Fig. 2),
which indicated that combined Res and IR deregulated the self-
renewal of GSCs and reduced the stemness of GSCs.
Programmed cell death is the predominant mechanism of death
induced by exposure to radiation. Recent studies have indicated
that the development of radioresistance is partly attributed to the
inhibition of apoptosis (18,40). Anti-apoptotic Bcl-2 family mem-
bers are shown to be frequently upregulated in various human
tumors, and they are also overexpressed in radioresistant pheno-
types of various cells (23,41). The radiosensitization efﬁciency of
Res was substantiated by performing cellular apoptosis assays.
Apoptosis in the co-treated group was more signiﬁcant than that in
the other groups at 48 h after IR as indicated by both annexin V-
FITC/PI and Hoechst 33258 staining (Fig. 4). These results were
consistent with the ﬁndings of another study that involved prostatecancer cells (42). In addition, autophagy, which is a catabolic pro-
cess involving the degradation of cytoplasmic proteins and organ-
elles through the lysosomal machinery, is also frequently activated
in tumor cells following anticancer therapies, such as chemother-
apeutic drugs or irradiation, and autophagy can either contribute to
cell death or represent a mechanism of resistance to these treat-
ments (6,21,28,43). Moreover, a complex interplay between cell
death and survival, including necrosis, apoptosis, and autophagy,
may govern tumor metastasis and subsequent carcinogenesis (44).
Thus, autophagy clearly played a dual role in cancer cells depending
on cell type, context, function time, or stage of tumor development.
Although the exact role of autophagy underlying glioma radio-
resistance has remained elusive, previous studies in our laboratory
have implicated that the induction of autophagy by curcumin or
rapamycin promotes differentiation of GSCs and their radiosensi-
tivity (21,27). Consistent with these observations, our data showed
that the basal activity of autophagy in the untreated GSCs was very
low, and radiation alone did not lead to a signiﬁcant change in LC3-
II level and Beclin-1. However, autophagy activity was remarkably
induced in groups following the administration of Res and IR
L. Wang et al. / Journal of Pharmacological Sciences 129 (2015) 216e225224(Fig. 3). These data suggested that the combination of Res and ra-
diation increased radiosensitization of GSCs partly because of the
induction of autophagy. De et al. recently proposed that a combi-
natorial approach of low-dose calorie restriction and Res can acti-
vate autophagy by inhibiting the mTOR pathway and/or by
activating the AMPK pathways to protect 26-month-old rat hearts
from doxorubicin-induced toxicity (45). However, the signaling
pathway involved in the induction of autophagy by Res and IR as a
mechanism of radiosensitization in GSCs needs further exploration,
and autophagy inhibitors or knockdown of autophagy should be
adopted to conﬁrm whether the increased radiosensitivity in GSCs
results from autophagy induction. Therefore, inhibition of the anti-
apoptotic functions of these Bcl-2 family members and inhibition of
the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR signaling
pathway regulating autophagy (46) should be investigated as a
strategy for increasing radiosensitivity of GSCs.
Moreover, DNA damage is one of the focal targets of radiation in
the cellular system, and the DNA repair pathway is one of the main
causes of resistance to radiation (34). Changes in the levels of DNA
repair proteins have been correlated with resistance to anti-cancer
strategies (47). We and others have reported that inhibition of the
DNA-dependent protein kinase catalytic subunit radiosensitizes
GSCs by inducing autophagy and apoptosis (48,49). Many studies
have also shown that natural compounds can inhibit DNA repair
machinery when coupled with radiation, thereby acting as radio-
sensitizing agents (50,51). In the present study, DNA damage in the
co-treated groupwasmore severe than that in the IR alone group at
3 and 12 h after irradiation as reﬂected by the tail length of the
comet (Fig. 5). Therefore, Res impaired the repair of radiation-
induced DNA damage in GSCs, which was reasonable to under-
stand its mechanism of radiosensitization.
Most encouragingly, the synergistic effect of Res and IR in
increasing radiosensitization of GSCs was applicable to animal
models in vivo. Combined treatment with Res and IR resulted in a
substantial growth delay and subsequent inhibition of the growth
rate of tumor in the mice bearing GSCs. Similarly, in the mice
bearing GSC xenograft tumors treated with Res and IR, LC3-II
signiﬁcantly increased and Bcl-2 remarkably decreased. In addi-
tion, double-membrane autophagosomes, as detected by TEM,
signiﬁcantly increased in the mice bearing GSCs treated with Res
and IR (Fig. 6). These results suggested that Res coupled apoptosis
with autophagy in IR mice bearing GSCs.
Our data demonstrated that the administration of Res and IR
was a potential therapeutic strategy for treating GBM. The radio-
sensitization effect of Res was supported by impairing the capacity
for DNA repair in the early stage, inhibition of proliferation and
stemness, induction of autophagy, and promotion of apoptosis
in vitro and in vivo. Collectively, these results demonstrated that
Res was a potential radiation sensitizer for malignant glioma
treatment and warrants further investigation.
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